Publications-ELK Biotechnology CO.,Ltd.

Technical

IF：5.1 Date：2024-05-31

Chemico-Biological Interactions

Kaempferol mitigates sepsis-induced acute lung injury by modulating the SphK1/ S1P/ SIPR1/ MLC2 signaling pathway to restore the integrity of the pulmonary endothelial cell barrier

Products： ELK9484
IF：5.1 Date：2025-02-18

ACS Pharmacology & Translational Science

Relaxin-2 Exhibits a Beneficial Role in Energy Metabolism to Alleviate Atrial Fibrillation Susceptibility

Products： ELK7181
IF：5.1 Date：2025-08-15

LIFE SCIENCES

M6A modification of RRM2 drives B cell hyperactivity in primary Sjögren's syndrome

Products： ELK10232、 ELK1390
IF：5.1 Date：2025-08-15

CANCER IMMUNOLOGY IMMUNOTHERAPY

Impact of stratifin/14-3-3σ on survival and interstitial lung disease in patients with non-small cell lung cancer receiving immune checkpoint inhibitors

Products： ELK3118

< Page of 331 >